Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan.
about
EFNS guideline on the drug treatment of migraine - report of an EFNS task forceEUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associationsItalian guidelines for primary headaches: 2012 revised versionMaternal characteristics and migraine pharmacotherapy during pregnancy: cross-sectional analysis of data from a large cohort study.Patterns and predictors of analgesic use in pregnancy: a longitudinal drug utilization study with special focus on women with migraineSafety of triptans for migraine headaches during pregnancy and breastfeeding.Pregnancy and chronic headache.Sex hormones and chronic headache in women.Headache in pregnancy: a nuisance or a new sense?Treatment of migraine headaches with sumatriptan in pregnancy.Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004.Migraine headaches and preeclampsia: an epidemiologic review.Triptans in pregnancy.Clinical pharmacology of the serotonin receptor agonist, zolmitriptan.Managing headache during pregnancy and lactation.The pharmacological management of migraine, part 2: preventative therapy.Treatment of cluster headache in pregnancy and lactation.Migraine therapy during pregnancy and lactation.Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.An update in the treatment of neurologic disorders during pregnancy--focus on migraines and seizures.The pathophysiological and pharmacological basis of current drug treatment of migraine headache.Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.Ongoing Pharmacological Management of Chronic Pain in Pregnancy.Pharmacological treatment of migraine during pregnancy and breastfeeding.Triptan safety during pregnancy: a Norwegian population registry study.Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure.Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure.Use of 5-HT1 agonists in pregnancy.Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.Delivery outcome after maternal use of drugs for migraine: a register study in Sweden.Migraine and preterm birth.Headache and pregnancy: a systematic review.Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study.Triptans or Not? This Is the Question. Management of Migraine Attacks During Pregnancy.Chronic pain during pregnancy: a review of the literature.
P2860
Q28219436-379035DC-ADF6-478F-B5D7-51F71619C134Q28817912-998C34ED-15BF-4AE5-A17C-E415EC4645BEQ30466790-E1F07AFA-B26F-4AB1-AE2A-533B4E8BFCC1Q33515892-E6379635-DD8F-474C-B4A2-BFF5A5063831Q33908591-ECC4B424-6A4F-4642-B1D9-005B482B6482Q33989015-048CBA4A-7598-46EA-B642-0181A05026BCQ34588676-0ABB5D9C-58FC-4BE7-9B61-C561DE06F863Q34829355-CCBF5AF0-19BC-4DD8-A2D6-5B73DF602916Q35837966-AEAACCC4-FC9C-4416-8943-55B6A7202473Q35865451-1A18BE6D-06C8-4111-BDDF-A29915EC334BQ36234257-77FB8272-74FD-4308-817F-D4C84036F49BQ36462139-11162289-1A4A-4C28-ABE6-25C7964B4A21Q36817033-74DD9270-101B-4BAA-A4B6-C9AF6633182AQ37008907-B24E11BB-EDB2-4003-9A26-B376B73EBE64Q37111889-26D0C3D0-386C-444D-B09B-4E6101F1FD42Q37313626-ACFDA282-5903-432F-B5BC-D653AF64156CQ37377970-D8CC0648-B359-4C53-8E07-508E12CFAE05Q37775960-101E54AD-1643-4140-985D-5F7ADB9BB100Q37996578-32528016-B578-46EA-A091-C454DA183F3BQ38006916-BF26FEAC-3DE0-47E2-808A-C5DD15C0130AQ38105147-84015084-2465-42AE-9E95-9EABD00B0EF4Q38341496-DF11DD4D-42D4-4FB9-A91E-EC455B7E2ACCQ38827847-1DFBD411-1EFD-4138-BE68-D63EA91091F3Q43063871-421BB7CF-A57D-44C2-8266-56D45D7F43C2Q44696855-8113049B-C436-478B-80F1-F4F42B30CA07Q44794058-626EA3DD-C35D-461C-A8E5-07ADE01400E9Q45031681-8A0C4E8C-7284-45C5-9537-4D6F9C0F49CBQ45112419-80169018-43F7-4D3D-B311-D79779C7BCE8Q46004711-12DF5164-2115-4038-90A5-41A0BC5FD277Q46226323-F37415D6-BA90-42FE-A29B-1E069F7F9B0DQ46328972-C25EB7F6-A9F1-464F-B0FA-117089E1DDF4Q47146399-963CA13D-BB14-4E79-805E-7E24A6229E7AQ50431359-4A8FBF73-8808-4CD7-9860-76BBD4662D8DQ53698632-7DFB40CB-3893-4A88-A765-FD8445FA5F4AQ55054322-297D7D76-650D-4077-AB54-5B308BE77EE6
P2860
Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Delivery outcome in women who ...... cial reference to sumatriptan.
@en
Delivery outcome in women who ...... cial reference to sumatriptan.
@nl
type
label
Delivery outcome in women who ...... cial reference to sumatriptan.
@en
Delivery outcome in women who ...... cial reference to sumatriptan.
@nl
prefLabel
Delivery outcome in women who ...... cial reference to sumatriptan.
@en
Delivery outcome in women who ...... cial reference to sumatriptan.
@nl
P2860
P1433
P1476
Delivery outcome in women who ...... cial reference to sumatriptan.
@en
P2093
P2860
P304
P356
10.1046/J.1526-4610.2001.111006351.X
P577
2001-04-01T00:00:00Z